U.S. regulators to examine testosterone therapy as use by menopausal women rises
The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
· 9/18/2026, 5:17:54 PM· 2 min read
The lack of a female-specific product creates practical challenges for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage
Read original story →
